The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: busulfan     Quarter: 2016Q3

Total Drug/Injury Combinations: 112     Number of Pages: 6

DRUGNAME PT EventCount
BUSULFAN. Endometrial atrophy 1 view events
BUSULFAN. Endometrial disorder 1 view events
BUSULFAN. Endometritis 1 view events
BUSULFAN. Engraft failure 1 view events
BUSULFAN. Epstein-Barr virus infection 1 view events
BUSULFAN. Febrile neutropenia 1 view events
BUSULFAN. Fluid retention 1 view events
BUSULFAN. Gastrointestinal toxicity 1 view events
BUSULFAN. Graft versus host disease in gastrointestinal tract 1 view events
BUSULFAN. Graft versus host disease in lung 1 view events
BUSULFAN. Graft versus host disease in skin 1 view events
BUSULFAN. Haemoglobin decreased 1 view events
BUSULFAN. Hepatic enzyme increased 1 view events
BUSULFAN. Hepatic failure 1 view events
BUSULFAN. Hepatic necrosis 1 view events
BUSULFAN. Hepatomegaly 1 view events
BUSULFAN. Herpes simplex 1 view events
BUSULFAN. Hypertension 1 view events
BUSULFAN. Ileal perforation 1 view events
BUSULFAN. Immune reconstitution inflammatory syndrome 1 view events

Total Drug/Injury Combinations: 112     Number of Pages: 6

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)